Cutera (NASDAQ:CUTR) Cut to “Hold” at ValuEngine

ValuEngine downgraded shares of Cutera (NASDAQ:CUTR) from a buy rating to a hold rating in a research note released on Tuesday morning, ValuEngine reports.

Other equities analysts have also issued research reports about the stock. Maxim Group restated a hold rating on shares of Cutera in a research report on Friday, August 9th. Sidoti downgraded shares of Cutera from a buy rating to a neutral rating in a research report on Thursday, August 22nd. Stephens lifted their price objective on shares of Cutera from $35.00 to $45.00 and gave the company an overweight rating in a research report on Friday, November 8th. BidaskClub raised shares of Cutera from a buy rating to a strong-buy rating in a research note on Tuesday, November 5th. Finally, Zacks Investment Research cut shares of Cutera from a hold rating to a sell rating in a research report on Wednesday, November 13th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company. Cutera currently has a consensus rating of Hold and a consensus price target of $40.00.

NASDAQ:CUTR traded up $0.23 during midday trading on Tuesday, reaching $37.32. 4,273 shares of the company traded hands, compared to its average volume of 171,981. Cutera has a twelve month low of $12.32 and a twelve month high of $39.15. The firm has a market capitalization of $533.31 million, a price-to-earnings ratio of -16.89 and a beta of 0.96. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.66 and a quick ratio of 1.05. The company has a fifty day moving average price of $34.15 and a 200 day moving average price of $27.16.

Cutera (NASDAQ:CUTR) last issued its earnings results on Thursday, November 7th. The medical device company reported $0.15 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.08) by $0.23. The firm had revenue of $46.12 million for the quarter, compared to analyst estimates of $41.66 million. Cutera had a negative return on equity of 84.67% and a negative net margin of 20.84%. The firm’s revenue for the quarter was up 13.7% on a year-over-year basis. During the same period last year, the company earned $0.11 earnings per share. On average, equities research analysts forecast that Cutera will post -0.71 earnings per share for the current fiscal year.

A number of institutional investors have recently made changes to their positions in CUTR. Strs Ohio acquired a new position in Cutera during the second quarter worth $423,000. Gamco Investors INC. ET AL boosted its position in shares of Cutera by 2.0% during the 2nd quarter. Gamco Investors INC. ET AL now owns 1,122,546 shares of the medical device company’s stock worth $23,327,000 after purchasing an additional 21,745 shares in the last quarter. Eagle Asset Management Inc. boosted its position in shares of Cutera by 12.1% during the 2nd quarter. Eagle Asset Management Inc. now owns 123,693 shares of the medical device company’s stock worth $2,570,000 after purchasing an additional 13,328 shares in the last quarter. State Board of Administration of Florida Retirement System grew its stake in shares of Cutera by 6.5% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 12,310 shares of the medical device company’s stock worth $256,000 after purchasing an additional 750 shares during the period. Finally, Stone Ridge Asset Management LLC acquired a new position in shares of Cutera during the 2nd quarter worth $267,000. 91.46% of the stock is currently owned by hedge funds and other institutional investors.

About Cutera

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Further Reading: How is a price target determined?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.